Hiloprobe

Hiloprobe is a research-based company in the cancer diagnostic field. Hiloprobe is developing ColoNode® – a biomarker test for the accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients.

Hiloprobe joined NOME in 2022 and is headed by Lina Olsson.

Company details

Website

Hiloprobe.se

More companies

MetsystemNOME2024-04-15T10:43:58+00:00

Metsystem
Metsystem

Digital Health
Droplet IVNOME2024-04-15T08:52:38+00:00

Droplet IV
Droplet IV

Medical Devices
Strike PharmaNOME2024-04-15T08:48:25+00:00

Strike Pharma
Strike Pharma

Therapeutics
InossiaNOME2024-04-15T08:43:52+00:00

Inossia
Inossia

Medical Devices
Linio BiotechNOME2024-04-15T08:37:31+00:00

Linio Biotech
Linio Biotech

Medical Devices
BrainCaptureNOME2024-04-15T08:32:40+00:00

BrainCapture
BrainCapture

Digital Health
2N PharmaNOME2024-04-15T08:22:22+00:00

2N Pharma
2N Pharma

Other, Therapeutics
One-Carbon TherapeuticsNOME2024-04-15T08:21:33+00:00

One-Carbon Therapeutics
One-Carbon Therapeutics

Other, Therapeutics

VIEW ALL PROJECTS

Hiloprobe

Project Description

Hiloprobe

Company details

Website

More companies